Outcomes of laparoscopic versus open liver resection in patients with large or huge HCC: a multicenter study.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 4/4)
유사 논문P · Population 대상 환자/모집단
560 patients undergoing OLR and 421 patients undergoing LLR based on predefined inclusion criteria.
I · Intervention 중재 / 시술
Outcomes of laparoscopic
C · Comparison 대조 / 비교
open liver resection in patients with large or huge HCC
O · Outcome 결과 / 결론
Similarly, in huge HCC, the LLR group showed reduced blood loss and faster recovery compared to the OLR group. [CONCLUSION] LLR is a safe and effective alternative to OLR for selected patients with large or huge HCC, offering superior perioperative outcomes while maintaining equivalent long-term survival.
[BACKGROUND] This study aimed to compare both perioperative and oncological outcomes between laparoscopic liver resection (LLR) and open liver resection (OLR) for patients with large (5-10 cm) or huge
APA
Yang S, Zhang W, et al. (2026). Outcomes of laparoscopic versus open liver resection in patients with large or huge HCC: a multicenter study.. Surgical endoscopy, 40(3), 2165-2177. https://doi.org/10.1007/s00464-025-12482-x
MLA
Yang S, et al.. "Outcomes of laparoscopic versus open liver resection in patients with large or huge HCC: a multicenter study.." Surgical endoscopy, vol. 40, no. 3, 2026, pp. 2165-2177.
PMID
41408435
Abstract
[BACKGROUND] This study aimed to compare both perioperative and oncological outcomes between laparoscopic liver resection (LLR) and open liver resection (OLR) for patients with large (5-10 cm) or huge (> 10 cm) hepatocellular carcinoma (HCC).
[METHODS] This study analyzed consecutive patients with large or huge HCC who underwent either LLR or OLR across eight medical centers between January 2015 and December 2021. Clinical data were collected from prospectively maintained databases. To address potential selection bias inherent in retrospective studies, we performed 1:1 propensity score matching (PSM) analysis.
[RESULTS] We enrolled 560 patients undergoing OLR and 421 patients undergoing LLR based on predefined inclusion criteria. After PSM (369 patients per group), the LLR group demonstrated superior perioperative outcomes compared to the OLR group, including significantly reduced operative duration, decreased intraoperative blood loss, and shorter hospitalization. Long-term oncological outcomes were comparable between approaches, with no significant differences in overall survival (OS) or recurrence-free survival (RFS). Multivariate Cox regression identified several independent prognostic factors for both OS and RFS: serum alpha-fetoprotein > 400 ng/mL, tumor size (both 5-10 cm and > 10 cm), multifocal disease, and microvascular invasion. Subgroup analyses confirmed the advantages of LLR across tumor size categories. For large HCC, LLR patients exhibited significantly less blood loss and shorter hospital stays. Similarly, in huge HCC, the LLR group showed reduced blood loss and faster recovery compared to the OLR group.
[CONCLUSION] LLR is a safe and effective alternative to OLR for selected patients with large or huge HCC, offering superior perioperative outcomes while maintaining equivalent long-term survival.
[METHODS] This study analyzed consecutive patients with large or huge HCC who underwent either LLR or OLR across eight medical centers between January 2015 and December 2021. Clinical data were collected from prospectively maintained databases. To address potential selection bias inherent in retrospective studies, we performed 1:1 propensity score matching (PSM) analysis.
[RESULTS] We enrolled 560 patients undergoing OLR and 421 patients undergoing LLR based on predefined inclusion criteria. After PSM (369 patients per group), the LLR group demonstrated superior perioperative outcomes compared to the OLR group, including significantly reduced operative duration, decreased intraoperative blood loss, and shorter hospitalization. Long-term oncological outcomes were comparable between approaches, with no significant differences in overall survival (OS) or recurrence-free survival (RFS). Multivariate Cox regression identified several independent prognostic factors for both OS and RFS: serum alpha-fetoprotein > 400 ng/mL, tumor size (both 5-10 cm and > 10 cm), multifocal disease, and microvascular invasion. Subgroup analyses confirmed the advantages of LLR across tumor size categories. For large HCC, LLR patients exhibited significantly less blood loss and shorter hospital stays. Similarly, in huge HCC, the LLR group showed reduced blood loss and faster recovery compared to the OLR group.
[CONCLUSION] LLR is a safe and effective alternative to OLR for selected patients with large or huge HCC, offering superior perioperative outcomes while maintaining equivalent long-term survival.
MeSH Terms
Humans; Liver Neoplasms; Carcinoma, Hepatocellular; Laparoscopy; Female; Male; Hepatectomy; Middle Aged; Aged; Retrospective Studies; Treatment Outcome; Operative Time; Propensity Score; Blood Loss, Surgical; Tumor Burden; Length of Stay
같은 제1저자의 인용 많은 논문 (5)
- Splicing factor SF3B4 promotes mitochondrial glutamine metabolism in hepatocellular carcinoma by regulating GLS1 isoform switching.
- The quality and reliability of short videos on acute myeloid leukemia on Bilibili and TikTok: A cross-sectional study.
- DNAJA1 as a modulator of CD8 T-cell function and prognosis in lung cancer: implications for immune regulation and therapeutic targeting.
- Application and Progress of Functional Lung Avoidance Radiotherapy for Lung Cancer.
- Surface expression of antitoxin on engineered bacteria neutralizes genotoxic colibactin in the gut.